Oculus Innovative Sciences to Reschedule New York City Financial Analysts Presentation Originally Scheduled for November 5th Due to Impact of Storm Sandy

        Print
| Source: Oculus Innovative Sciences, Inc.

PETALUMA, Calif., Nov. 2, 2012 (GLOBE NEWSWIRE) -- Oculus Innovative Sciences, Inc. (Nasdaq:OCLS), today announced it will reschedule its 2012 New York City Financial Analysts Presentation originally scheduled for November 5, 2012, due to the impact of the recent storm. Moderated by Suraj Kalia, senior vice president of Northland Capital Markets, the new date of the presentation will be announced next week.

About Oculus Innovative Sciences

Oculus Innovative Sciences is a commercial healthcare company that designs, produces and markets innovative, safe and effective drugs, devices, and nutritional products. Oculus is pioneering innovative solutions in multiple markets for the dermatology, surgical, wound care, and animal healthcare markets, and has commercialized products in the United States, Europe, India, China, Mexico and select Middle East countries. The company's headquarters are in Petaluma, California, with manufacturing operations in the United States and Latin America. More information can be found at www.oculusis.com

Media and Investor Contact:
Oculus Innovative Sciences, Inc.
Dan McFadden
Director of Public and Investor Relations
(425) 753-2105